TB-500 Results Timeline
What the standard TB-500 research protocol looks like phase by phase, over a typical 8–16 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce daily
CYCLE LENGTH8–16 weeks
DOSE RANGE500–1000 mcg/day
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2
Target dose: 500 mcg
Escalation
Weeks 3–4
Target dose: 600 mcg
Escalation
Weeks 5–8
Target dose: 750 mcg
Maintenance
Weeks 9–12
Target dose: 1000 mcg
Reported in Research
- ✓8–12 weeks; optional extension to 16 weeks.
- ✓Follow with a 2–4 week break before repeating.
This timeline reflects the structure of the standard TB-500 research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.